Search clinical trials for: Tc 99m EC20

Total 428 results

Endocyte

Completed

Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor

Head and Neck Cancer | Bladder Cancer | Pancreas Cancer | Testicular Cancer | Recurrent or Metastatic Cancer
Endocyte

Completed

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Women With Suspected Ovarian or Endometrial Cancer

Ovarian Cancer | Endometrial Cancer

United States
Endocyte

Completed

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

United States
Endocyte

Completed

Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors

Pituitary Tumors

United States
Endocyte

Completed

Safety and Biodistribution of Technetium Tc 99m EC20 in Normal Volunteers and Ovarian Cancer Patients

Ovarian Cancer | Healthy Volunteers

United States
Endocyte

Completed

Safety and Efficacy of Folatescan (Technetium TC 99M EC20) in Patients With Suspected Ovarian Carcinoma or Recurrent Endometrial Carcinoma

Recurrent Endometrial Carcinoma | Ovarian Carcinoma
Endocyte

Completed

Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma

Metastatic Renal Cell Carcinoma

United States
Memorial Health University Medical Center

Unknown

Tilmanocept vs Sulfur Colloid in Sentinel Lymph Node Biopsy

Breast Cancer | Sentinel Lymph Node Biopsy

United States
Oregon Health and Science University
Ionis Pharmaceuticals, Inc.

Recruiting

carDIo-ttranSSfOrm nucLEar Imaging Study (DISSOLvE)

Amyloidosis | Transthyretin Amyloid Cardiomyopathy

United States
Navidea Biopharmaceuticals

Recruiting

Comparison of Tc 99m Tilmanocept Quantitative Imaging With Immunohistochemical (IHC) Analysis of CD206 Expression in Synovial Tissue of Subjects With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

United States, United Kingdom
Navidea Biopharmaceuticals

Completed

Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT

Kaposi's Sarcoma

United States
University of California, San Diego

Recruiting

Dosimetry of Tc-99m-Tilmanocept

Diabetic Kidney Disease

United States
Washington University School of Medicine
Lloyd J. Old STAR Program

Terminated

Mapping Draining Lymph Nodes in CNS Malignancies

Central Nervous System Neoplasms | Central Nervous System Tumor

United States
Navidea Biopharmaceuticals

Completed

Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging

Rheumatoid Arthritis

United States
Navidea Biopharmaceuticals

Completed

Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes

Melanoma | Breast Cancer

United States
Johns Hopkins University
Cardinal Health

Terminated

Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection

Breast Cancer

United States
Far Eastern Memorial Hospital

Not yet recruiting

A Multi-center Cardiac PYP Scan Registry in Taiwan.

Heart Failure | Cardiac Amyloidosis

Taiwan
Navidea Biopharmaceuticals

Completed

Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma

Melanoma | Breast Cancer

United States, Israel
Mathew S. Maurer
National Heart, Lung, and Blood Institute (NHLBI); Yale University; Boston Medical... and other collaborators

Recruiting

Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations (SCAN-MP)

Amyloid Cardiomyopathy, Transthyretin-Related

United States
Shanghai General Hospital, Shanghai Jiao Tong University...
NanoMab Technology (UK) Limited

Completed

99mTc Labeled Anti-PD-L1 sdAb SPECT/CT in Assessment of PD-L1 Expression in NSCLC

Non-Small Cell Lung Cancer

China
Boston Children's Hospital
Johns Hopkins University; University of Florida; National Institute for Biomedical...

Completed

Biokinetics Study for Tc-99m MAG3 in Pediatric Molecular Imaging

Renal Disease

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid

Eyelid Sebaceous Gland Carcinoma

United States
Boston Scientific Corporation

Completed

TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.

Hepatocellular Carcinoma

United States
University of Washington
National Cancer Institute (NCI)

Completed

SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy

Lung Carcinoma | Malignant Neoplasm

United States
University Hospital Inselspital, Berne

Active, not recruiting

ATTR Amyloidosis in Elderly Patients With Aortic Stenosis

Aortic Stenosis Symptomatic | Amyloidosis Cardiac

Switzerland
Case Comprehensive Cancer Center
National Cancer Institute (NCI); Mitaka USA, Inc.

Completed

Comparison of Use of Indocyanine Green and 99mTc-labeled Radiotracer for Axillary Lymphatic Mapping in Patients With Breast Cancer

Stage I Breast Cancer | Stage II Breast Cancer

United States
Assiut University

Not yet recruiting

Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies

Bone Metastases | Urogenital Cancer
University of North Carolina, Chapel Hill
National Institute of General Medical Sciences (NIGMS)

Completed

Effect of Non-Alcoholic Steatohepatitis (NASH) on the Pharmacokinetics of 99mTechnetium-Mebrofenin

Non-alcoholic Steatohepatitis

United States
Buddhist Tzu Chi General Hospital

Completed

18F-fluorocholine PET/CT for Hyperparathyroidism

Hyperparathyroidism

Taiwan
IRCCS San Raffaele

Recruiting

Imaging Guided Surgery to Improve the Detection of Lymph Node Metastases in Prostate Cancer Patients

Prostate Cancer

Italy
John O. Prior

Terminated

Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic Melanoma (Tilmanocept)

Melanoma

Switzerland
Reiley Pharmaceuticals Inc.

Unknown

[Tc-99m]-RPI-087 as an Imaging Marker in Osteoarthritis of the Knee Compared to Healthy Volunteers

Healthy | Osteo Arthritis Knee

Canada
Mayo Clinic

Recruiting

Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities

Breast Neoplasm

United States
Proactina S.A.
Pharmathen S.A.; ConsulTech GmbH; pharmtrace

Completed

Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With Glioma

Glioma (Diagnosis)

Hungary, France
Universitaire Ziekenhuizen KU Leuven

Withdrawn

Ictal SPECT With Intra-arterial Injection

Epilepsy

Belgium
University of California, San Diego
Cardinal Health 414, LLC

Terminated

Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium

Endometrial Cancer

United States
National Taiwan University Hospital

Recruiting

A Proof-of-concept Study Evaluating the Microbiota-gut-brain Axis

Parkinson Disease

Taiwan
Edwin Wu
Astellas Pharma Global Development, Inc.

Terminated

Half-Dose Radiopharmaceutical in Wide Beam Reconstruction (REGA-1102)

Myocardial Infarction | Ischemic Heart Disease

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer

Breast Cancer

United States
Navidea Biopharmaceuticals

Completed

An Evaluation of the Safety of Intravenous Tc 99m Tilmanocept and a Comparison of Imaging With Sulfur Colloid in Subjects With and Without NASH

Nonalcoholic Steatohepatitis | NASH - Nonalcoholic Steatohepatitis

United States
National Cancer Institute (NCI)

Completed

PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy

Cancer

United States
Tel-Aviv Sourasky Medical Center

Unknown

The Added Value of Quantification of Lung Function in Patients Undergoing Radiotherapy, Using Tc-99m-MAA SPECT-CT

Lung Cancer
Tel-Aviv Sourasky Medical Center

Completed

The Added Value of Hybrid Functional Anatomical Imaging PET-CT and SPECT-CT in Patients Treated With Y-90 SIRT for Liver Malignancies

Primary Liver Tumor, Metastatic Liver

Israel
Otsuka Pharmaceutical Co., Ltd.
Covance

Completed

Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic Subjects

Dyspeptic Subjects

United States
Navidea Biopharmaceuticals

Terminated

Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma (HNSCC)

United States
University of Washington
National Cancer Institute (NCI)

Completed

FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging

Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage IIIB Lung Non-Small Cell Cancer AJCC v7

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer

Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Diagnostic Trial in Patients Who Are Undergoing Surgery for Early Stage Mouth Cancer

Head and Neck Cancer
University of Manitoba
Winnipeg Regional Health Authority

Terminated

Sodium Pertechnetate (99Tc) Injection Generator: 99mTc From Neutron-activation 99Mo v 99mTc From Fission 99Mo

Cancer of Bone

Canada
Centre Paul Strauss

Completed

Technetium Tc 99m Sulfur Colloid and Blue Dye In Detecting Sentinel Lymph Nodes in Patients With Breast Cancer

Breast Cancer

France

Search clinical trials for: Tc 99m EC20

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations